Sign in
Facet browsing currently unavailable
Page 4 of 1671 results
Sort by: relevance publication year
|
Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain JOURNAL ARTICLE published 29 November 2021 in Alzheimer's Research & Therapy Research funded by beijing science and technology planning project (Z161100000216134) | national natural science foundation of china (81430044) |
|
A nonhuman primate model with Alzheimer’s disease-like pathology induced by hippocampal overexpression of human tau JOURNAL ARTICLE published 27 January 2024 in Alzheimer's Research & Therapy Research funded by Guangdong Provincial Department of Science and Technology (2018B030332001) | Guangzhou Municipal Science and Technology Bureau (202206060002,202206060002) | National Natural Science Foundation of China (31970906) | Natural Science Foundation of Guangdong Province (2020A1515010083) |
|
The course of primary progressive aphasia diagnosis: a cross-sectional study JOURNAL ARTICLE published December 2022 in Alzheimer's Research & Therapy |
|
Prevalence of mixed pathologies in the aging brain JOURNAL ARTICLE published December 2014 in Alzheimer's Research & Therapy |
|
Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy JOURNAL ARTICLE published 23 April 2024 in Alzheimer's Research & Therapy Research funded by Dutch Heart Foundation (2012 T077,2019 T060,2016 T086) | the Netherlands Organisation for Health Research and Development (ZonMw; 015008048,ZonMW, nr. 733050822) | National Institutes of Health, USA (5R01NS104147-02) | The Galen and Hilary Weston Foundation (NR170024) | The Netherlands Organization for Health Research and Development (DR-2019-00299) | Alzheimer’s Disease Research program of the BrightFocus Foundation (A2021007F) | from the Netherlands Organisation for Health Research and Development (91717337) |
|
Simulations of symptomatic treatments for Alzheimer's disease: computational analysis of pathology and mechanisms of drug action JOURNAL ARTICLE published 2012 in Alzheimer's Research & Therapy |
|
Granulovacuolar degeneration bodies are independently induced by tau and α-synuclein pathology JOURNAL ARTICLE published 14 December 2022 in Alzheimer's Research & Therapy Research funded by Alzheimer Nederland (#WE.03-2017-10) | Coby van Nieuwkerk fonds (Hersenstichting Nederland #DR-2019-00278) |
|
The need for thorough phase II studies in medicines development for Alzheimer’s disease JOURNAL ARTICLE published December 2015 in Alzheimer's Research & Therapy |
|
Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software JOURNAL ARTICLE published December 2015 in Alzheimer's Research & Therapy |
|
Phenotypic differences between apolipoprotein E genetic subgroups: research and clinical implications JOURNAL ARTICLE published 2012 in Alzheimer's Research & Therapy |
|
ABT-126 monotherapy in mild-to-moderate Alzheimer’s dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension JOURNAL ARTICLE published December 2016 in Alzheimer's Research & Therapy |
|
Leading mediators of sex differences in the incidence of dementia in community-dwelling adults in the UK Biobank: a retrospective cohort study JOURNAL ARTICLE published 9 January 2023 in Alzheimer's Research & Therapy Research funded by Postdoctoral Research Funds of Guangdong Provincial People’s Hospital (BY012021047) | High-level Talent Flexible Introduction Fund of Guangdong Provincial People’s Hospital (KJ012019530) |
|
Olfactory function is associated with cognitive performance: results from the population-based LIFE-Adult-Study JOURNAL ARTICLE published December 2019 in Alzheimer's Research & Therapy |
|
Heterogeneity of Alzheimer’s disease: consequence for drug trials? JOURNAL ARTICLE published December 2018 in Alzheimer's Research & Therapy |
|
Correction to: Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer’s disease JOURNAL ARTICLE published December 2019 in Alzheimer's Research & Therapy |
|
Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline JOURNAL ARTICLE published December 2021 in Alzheimer's Research & Therapy |
|
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy JOURNAL ARTICLE published December 2019 in Alzheimer's Research & Therapy |
|
Normalization of CSF pTau measurement by Aβ40 improves its performance as a biomarker of Alzheimer’s disease JOURNAL ARTICLE published December 2020 in Alzheimer's Research & Therapy |
|
Retraction Note: Increased Aβ42-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer’s disease pathogenesis JOURNAL ARTICLE published December 2022 in Alzheimer's Research & Therapy |
|
First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer’s disease JOURNAL ARTICLE published December 2016 in Alzheimer's Research & Therapy |